Tisotumab Vedotin as Second or Third-Line Therapy for Recurrent Cervical Cancer
1. Median overall survival was 11.5 months in the tisotumab vedotin group and 9.5 months in the...
Read MoreJul 16, 2024
1. Median overall survival was 11.5 months in the tisotumab vedotin group and 9.5 months in the...
Read MoreJul 16, 2024
MONDAY, July 15, 2024 (HealthDay News) — When it comes to health worries, cancer leads the...
Read MoreJul 16, 2024
MONDAY, July 15, 2024 (HealthDay News) — For patients with private insurance undergoing...
Read MoreJul 16, 2024
MONDAY, July 15, 2024 (HealthDay News) — An estimated 40.0 percent of all incident cancer...
Read MoreJul 16, 2024
MONDAY, July 15, 2024 (HealthDay News) — A considerable proportion of women aged 39 to 49...
Read MoreJul 15, 2024
In a recent study of supportive care for advanced cancer management, targeted palliative care optimized patient care and enhanced clinical outcomes.
Read MoreJul 15, 2024
Non-small cell lung cancer (NSCLC) patients with EGFR mutations exhibit an unfavorable response to immune checkpoint inhibitor (ICI) monotherapy, and their tumor microenvironment (TME) is usually immunosuppressed. TGF-β plays an...
Read MoreJul 15, 2024
Neoadjuvant chemotherapy (NACT) is a viable therapeutic option for women diagnosed locally advanced cervical cancer (LACC). However, the factors influencing pathological response are still controversial. We collected pair...
Read MoreJul 15, 2024
Over 50% of breast cancer cases are “Human epidermal growth factor receptor 2 (HER2) low breast cancer (BC)”, characterized by HER2 immunohistochemistry (IHC) scores of 1+ or 2+ alongside no amplification on...
Read MoreJul 13, 2024
The following is a summary of “Impacts of social determinants of health on chronic opioid therapy...
Read MoreJul 13, 2024
Click here to read this study in Nature Medicine. ©2024 2 Minute Medicine, Inc. All rights...
Read MoreJul 12, 2024
The following is a summary of “Stereotactic Body Proton Therapy Versus Conventionally Fractionated...
Read MoreJul 12, 2024
The following is a summary of “Clinical considerations for sexual and gender minorities with...
Read MoreJul 12, 2024
THURSDAY, July 11, 2024 (HealthDay News) — Compared with their urban counterparts, rural...
Read MoreJul 12, 2024
THURSDAY, July 11, 2024 (HealthDay News) — For patients with type 2 diabetes (T2D),...
Read MoreJul 12, 2024
THURSDAY, July 11, 2024 (HealthDay News) — For men undergoing locoregional staging of...
Read MoreJul 11, 2024
WEDNESDAY, July 10, 2024 (HealthDay News) — For Black adults at risk for endometrial cancer...
Read MoreJul 11, 2024
WEDNESDAY, July 10, 2024 (HealthDay News) — For cancer survivors, higher adherence to a...
Read MoreJul 10, 2024
For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month...
Read MoreJul 10, 2024
Electronic cigarette use is associated with a lower use of lung cancer screening (LCS), according...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.